CU

Chandan Upadhyay

Director Director DIN 01273005
DIN 01273005 First appointment Jul 2013 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jul 2013
Shareholding value Locked Premium profile

About Chandan Upadhyay

Data last updated:

Chandan Upadhyay has 13 years in corporate governance. Formerly with 1 company, such as Luxuriate Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 01273005
Primary Designation Director
First Appointment 01 Jul 2013
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Additional Director01 Jul 20132013Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Luxuriate Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Chandan Upadhyay

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chandan Upadhyay

Chandan Upadhyay has 13 years in corporate governance. Formerly with 1 company, such as Luxuriate Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Chandan Upadhyay is associated with 0 companies as a director.

Chandan Upadhyay has expertise in General Business.

Chandan Upadhyay has 13 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available